Meningococcal vaccine group B OMV - NIPH
Alternative Names: Meningococcal vaccine group B outer membrane vesicle vaccine - NIPHLatest Information Update: 15 Aug 2007
At a glance
- Originator Norwegian Institute of Public Health
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Meningococcal group B infections
Most Recent Events
- 09 Jul 2004 No development reported - Clinical-Phase-Unknown for Meningococcal group B infections in Chile (IM)
- 09 Jul 2004 No development reported - Clinical-Phase-Unknown for Meningococcal group B infections in Iceland (IM)
- 09 Jul 2004 No development reported - Phase-III for Meningococcal group B infections in Norway (IM)